Omnicell (OMCL) Current Assets (2010 - 2026)
Omnicell's (OMCL) quarterly Current Assets came in at $735.4 million in Q2 2026, down 12.95% year-over-year from $844.8 million in Q2 2025, and up 1.81% quarter-over-quarter from $722.3 million in Q1 2026.
Analysis
Omnicell (OMCL) Current Assets (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Current Assets for 17 consecutive years, with $735.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Assets fell 12.95% year-over-year to $735.4 million in Q2 2026; TTM through Jun 2026 was $735.4 million, a 12.95% decrease from a year earlier, with the FY2025 full-year figure at $680.1 million, down 16.61% from the prior year.
- Current Assets was $735.4 million for Q2 2026 at Omnicell, up from $722.3 million in the prior quarter.
- Over five years, Current Assets peaked at $1.0 billion in Q3 2024 and troughed at $659.6 million in Q3 2025.
- A 5-year average of $847.0 million and a median of $847.0 million in 2022 frame the typical range for Current Assets.
- Across the five-year window, Current Assets gained 20.55% in 2023 and tumbled 34.77% in 2025, its largest moves.
- Over 5 years, Current Assets stood at $881.8 million in 2022, then gained by 5.19% to $927.6 million in 2023, then declined by 12.08% to $815.5 million in 2024, then fell by 16.61% to $680.1 million in 2025, then increased by 8.13% to $735.4 million in 2026.
- The last three Current Assets figures came in at $735.4 million (Q2 2026), $722.3 million (Q1 2026), and $680.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 9.54 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 24.39 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 14.42 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 7.97 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 6.82 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 6.62 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 4.09 Bn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 4.32 Bn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 735.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 735.39 Mn |
| Mar 31, 2026 | 722.30 Mn |
| Dec 31, 2025 | 680.07 Mn |
| Sep 30, 2025 | 659.62 Mn |
| Jun 30, 2025 | 844.78 Mn |
| Mar 31, 2025 | 839.67 Mn |
| Dec 31, 2024 | 815.49 Mn |
| Sep 30, 2024 | 1.01 Bn |
| Jun 30, 2024 | 995.67 Mn |
| Mar 31, 2024 | 989.92 Mn |
| Dec 31, 2023 | 927.57 Mn |
| Sep 30, 2023 | 913.75 Mn |
| Jun 30, 2023 | 881.36 Mn |
| Mar 31, 2023 | 934.97 Mn |
| Dec 31, 2022 | 881.81 Mn |
| Sep 30, 2022 | 849.13 Mn |
| Jun 30, 2022 | 787.77 Mn |
| Mar 31, 2022 | 775.60 Mn |
| Dec 31, 2021 | 780.70 Mn |
| Sep 30, 2021 | 888.72 Mn |